Boston Scientific has lifted its fiscal year 2025 (FY25) profit outlook to between $3.02 and $3.04 per share amid continued ...

Germany-based roclub has raised $11.7m to fuel the US launch of its platform for the remote operation (teleoperation) of ...

Demand for gender-specific medical innovation means that medtech devices related to women’s health are drawing investor ...

Adagio Medical has secured $19m upfront through a private placement, aimed at advancing its ULTC technology for VT treatment.

Biocomposites has launched its SYNICEM range of spacers for hip, knee, and shoulder revision surgery in the US.

BD has launched the Incada Connected Care Platform, an AI-powered cloud-based system designed to integrate data from the ...

Efforts to address access issues to breast cancer treatment should include affordability, infrastructure, transportation, and ...

Diabetes Awareness Month highlights the condition's prevalence, risk factors, prevention, management and burden on healthcare ...

US-based Adaptyx Biosciences has secured $14m to scale its bio-wearable that translates molecular data into actionable ...

The overall IOL market is estimated to continue to grow at a steady rate as an ageing population increases the prevalence of ...

Samsung entities have joined forces with Grail to advance the availability of the Galleri test in the main Asian markets.

Boston Scientific has acquired Nalu Medical for around $533m, broadening the therapeutic scope of the medtech giant’s ...